Immunovant (IMVT) Insider Trading & Ownership $22.09 +0.02 (+0.10%) As of 12:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immunovant (NASDAQ:IMVT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$336.90 MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$6.78 M Get IMVT Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunovant stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMVT Insider Buying and Selling by Quarter Immunovant Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/22/2025Jay S StoutCTOSell2,195$23.59$51,780.05 1/22/2025Michael GeffnerInsiderSell2,657$23.59$62,678.63 1/15/2025Eva Renee BarnettCFOSell2,298$23.83$54,761.34 1/15/2025Peter SalzmannCEOSell8,767$23.83$208,917.61 1/15/2025William L MaciasInsiderSell2,383$23.83$56,786.89 1/13/2025Sciences Ltd. RoivantDirectorBuy16,845,010$20.00$336,900,200.00 1/8/2025Eva Renee BarnettCFOSell4,105$24.10$98,930.50 1/8/2025Peter SalzmannCEOSell5,105$24.10$123,030.50 11/20/2024Eva Renee BarnettCFOSell4,174$25.45$106,228.30 11/20/2024Eva Renee BarnettCFOSell4,174$25.45$106,228.30 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/20/2024Mark S LevineInsiderSell3,650$25.45$92,892.50 11/20/2024Peter SalzmannCEOSell16,692$25.45$424,811.40 11/20/2024Peter SalzmannCEOSell16,692$25.45$424,811.40 10/23/2024Jay S StoutCTOSell2,740$29.53$80,912.20 10/23/2024Mark S LevineInsiderSell4,361$29.53$128,780.33 10/16/2024Eva Renee BarnettCFOSell3,271$28.79$94,172.09 10/16/2024Peter SalzmannCEOSell9,095$28.79$261,845.05 10/16/2024William L MaciasInsiderSell3,188$28.79$91,782.52 10/9/2024Eva Renee BarnettCFOSell5,162$29.56$152,588.72 10/9/2024Peter SalzmannCEOSell4,460$29.56$131,837.60 7/24/2024Jay S StoutCTOSell2,813$27.76$78,088.88 7/24/2024Michael GeffnerInsiderSell3,456$27.76$95,938.56 7/17/2024Eva Renee BarnettCFOSell3,123$29.69$92,721.87 7/17/2024Mark S LevineInsiderSell2,505$29.69$74,373.45 7/17/2024Peter SalzmannCEOSell8,685$29.69$257,857.65 7/9/2024Eva Renee BarnettCFOSell4,747$28.06$133,200.82 7/9/2024Julia G ButchkoInsiderSell1,527$28.06$42,847.62 7/9/2024Peter SalzmannCEOSell4,619$28.06$129,609.14 5/22/2024Eva Renee BarnettCFOSell4,042$29.65$119,845.30 5/22/2024Julia G ButchkoInsiderSell3,247$29.65$96,273.55 5/22/2024Peter SalzmannCEOSell16,163$29.65$479,232.95 4/24/2024Jay S StoutCTOSell7,239$28.90$209,207.10 4/24/2024Michael GeffnerInsiderSell3,261$28.90$94,242.90 4/17/2024Eva Renee BarnettCFOSell12,253$29.06$356,072.18 4/17/2024Julia G ButchkoInsiderSell10,115$29.06$293,941.90 4/17/2024Peter SalzmannCEOSell34,079$29.06$990,335.74 4/9/2024Eva Renee BarnettCFOSell3,689$31.18$115,023.02 4/9/2024Julia G ButchkoInsiderSell1,053$31.18$32,832.54 4/9/2024Peter SalzmannCEOSell4,807$31.18$149,882.26 2/22/2024Eva Renee BarnettCFOSell2,930$36.15$105,919.50 URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now2/22/2024Mark S LevineInsiderSell2,134$36.15$77,144.10 (Data available from 1/1/2013 forward) IMVT Insider Trading Activity - Frequently Asked Questions Who is on Immunovant's Insider Roster? The list of insiders at Immunovant includes Eva Renee Barnett, Frank Torti, Jay S Stout, Julia G Butchko, Mark S Levine, Michael Geffner, Peter Salzmann, Sciences Ltd. Roivant, and William L Macias. Learn more on insiders at IMVT. What percentage of Immunovant stock is owned by insiders? 5.90% of Immunovant stock is owned by insiders. Learn more on IMVT's insider holdings. Which Immunovant insiders have been buying company stock? The following insider purchased IMVT shares in the last 24 months: Sciences Ltd. Roivant ($394,900,208.00). How much insider buying is happening at Immunovant? Insiders have purchased a total of 18,371,326 IMVT shares in the last 24 months for a total of $394,900,208.00 bought. Which Immunovant insiders have been selling company stock? The following insiders have sold IMVT shares in the last 24 months: Eva Renee Barnett ($2,396,158.24), Jay S Stout ($419,988.23), Julia G Butchko ($738,429.92), Mark S Levine ($964,453.35), Michael Geffner ($252,860.09), Peter Salzmann ($10,226,585.13), and William L Macias ($214,181.06). How much insider selling is happening at Immunovant? Insiders have sold a total of 602,470 Immunovant shares in the last 24 months for a total of $15,212,656.02 sold. Immunovant Key ExecutivesDr. Frank M. Torti M.B.A. (Age 45)M.D., Executive Chairperson of the Board Compensation: $92.5kDr. Peter Salzmann M.B.A. (Age 56)M.D., CEO & Director Compensation: $1.02MMs. Eva Renee Barnett M.B.A. (Age 43)Chief Financial Officer Compensation: $871.07k6 recent tradesDr. William L. Macias M.D. (Age 65)Ph.D., Chief Medical Officer Compensation: $719.88kDr. Jay S. Stout Ph.D. (Age 60)Chief Technology Officer Dr. Chau Cheng M.B.A.Ph.D., Vice President of Investor RelationsMr. Mark S. Levine (Age 51)Chief Legal Officer & Corporate Secretary 2 recent tradesMs. Lauren Schrier M.B.A.Vice President of MarketingMs. Christine BlodgettVice President of Human ResourcesDr. Julia G. Butchko Ph.D. (Age 53)Chief Development Officer Compensation: $531k More Insider Trading Tools from MarketBeat Related Companies CTLT Insider Trading PCVX Insider Trading SRPT Insider Trading ROIV Insider Trading BPMC Insider Trading BBIO Insider Trading RVMD Insider Trading LNTH Insider Trading ELAN Insider Trading CYTK Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:IMVT) was last updated on 1/31/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMVT Stock Alerts